Clinical Trials Browser

Recurrence × WW Domain-Containing Oxidoreductase × Plasma cell × Clear all

NCT00511238 2017-08-31

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

Phase 2 Completed

312 enrolled 16 charts

Multiple Myeloma, Recurrence